US Tariff Action Could Backfire and Hurt American Healthcare More than India: Experts
India’s pharmaceutical sector has responded strongly to US President Donald Trump’s recent announcement of a 25% tariff on all Indian…
India’s pharmaceutical sector has responded strongly to US President Donald Trump’s recent announcement of a 25% tariff on all Indian…
Credit: Sugandh Khandelwal India’s journey in the healthcare sector is nothing short of remarkable. From being a country heavily reliant…